Differences between randomized clinical trial participants and real-world empagliflozin users and the changes in their glycated hemoglobin levels

被引：0
|
作者：
Munk, Nicolai E. [1 ]
Knudsen, Jakob S. [1 ]
Pottegard, Anton [2 ]
Witte, Daniel R. [3 ,4 ,5 ]
Thomsen, Reimar W. [1 ]
机构：
[1] Aarhus Univ Hosp, Aarhus, Denmark
[2] Univ Southern Denmark, Odense, Denmark
[3] Aarhus Univ, Aarhus, Denmark
[4] Steno Diabet Ctr Aarhus, Aarhus, Denmark
[5] Danish Diabet Acad, Odense, Denmark
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
4342
引用
收藏
页码：129 / 130
页数：2
相关论文
共 50 条
  • [1] Differences Between Randomized Clinical Trial Participants and Real-World Empagliflozin Users and the Changes in Their Glycated Hemoglobin Levels
    Munk, Nicolai E.
    Knudsen, Jakob S.
    Pottegard, Anton
    Witte, Daniel R.
    Thomsen, Reimar W.
    JAMA NETWORK OPEN, 2020, 3 (02)
  • [2] Disparities between randomized clinical trial participants and sepsis patients in real-world
    Bai, Xue
    Zeng, Peng
    Wang, Bo
    Zhang, Zhongwei
    Jin, Xiaodong
    Kang, Yan
    Cheng, Yisong
    Wu, Qin
    JOURNAL OF CRITICAL CARE, 2023, 77
  • [3] Differences between randomized clinical trial patients and real-world initiators of liraglutide
    Knudsen, Jakob S.
    Thomsen, Reimar W.
    Pottegard, Anton
    Baggesen, Lisbeth M.
    Knop, Filip
    Sorensen, Henrik T.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 487 - 487
  • [4] Differences between clinical trial efficacy and real-world effectiveness
    Davidson, Michael H.
    AMERICAN JOURNAL OF MANAGED CARE, 2006, 12 (15): : S405 - S411
  • [5] Improving the Relationship Between the Randomized Clinical Trial and Real-World Clinical Practice
    Gottdiener, William H.
    PSYCHOTHERAPY, 2011, 48 (03) : 231 - 233
  • [6] Using real-world data for supporting regulatory decision making: Comparison of cardiovascular and safety outcomes of an empagliflozin randomized clinical trial versus real-world data
    Jang, Ha Young
    Kim, In-Wha
    Oh, Jung Mi
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] Trial participants vs real-world users of medicines: How different are they really and does it matter?
    Pottegard, Anton
    Klungel, Olaf
    Morales, Daniel
    Najafzadeh, Mehdi
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 298 - 299
  • [8] Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide
    Knudsen, Jakob Schollhammer
    Thomsen, Reimar Wernich
    Pottegard, Anton
    Knop, Filip Krag
    Sorensen, Henrik Toft
    DIABETES CARE, 2018, 41 (09) : E133 - E135
  • [9] Linking Clinical Trial Participants to Their US Real-World Data Through Tokenization: A Practical Guide
    Nielson, Carrie
    Eckrote, Michael
    Lu, Mike
    Shah, Rikisha Gupta
    Alexander, Tyler
    Low, Kim Wah
    Zhang, Zhiwei
    Eliazar, Austin
    Klesh, Reyna
    Kress, Andrew
    Bryant, Matt
    Asiimwe, Alex
    Gatto, Nicolle M.
    Dreyer, Nancy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 612 - 613
  • [10] CHANGES IN CONCEPTUAL STRUCTURE WITH EXPERTISE - DIFFERENCES BETWEEN REAL-WORLD EXPERTS AND NOVICES
    MURPHY, GL
    WRIGHT, JC
    JOURNAL OF EXPERIMENTAL PSYCHOLOGY-LEARNING MEMORY AND COGNITION, 1984, 10 (01) : 144 - 155
12345